profitadal 20 mg tabletki powlekane
aflofarm farmacja polska sp. z o.o. - tadalafilum - tabletki powlekane - 20 mg
xaleba 30 mg tabletki powlekane
accord healthcare polska sp. z o.o. - etoricoxibum - tabletki powlekane - 30 mg
xaleba 60 mg tabletki powlekane
accord healthcare polska sp. z o.o. - etoricoxibum - tabletki powlekane - 60 mg
xaleba 90 mg tabletki powlekane
accord healthcare polska sp. z o.o. - etoricoxibum - tabletki powlekane - 90 mg
xaleba 120 mg tabletki powlekane
accord healthcare polska sp. z o.o. - etoricoxibum - tabletki powlekane - 120 mg
subinit 12,5 mg kapsułki twarde
mt pharma-healthcare sp. z o.o. - sunitinibum - kapsułki twarde - 12,5 mg
subinit 25 mg kapsułki twarde
mt pharma-healthcare sp. z o.o. - sunitinibum - kapsułki twarde - 25 mg
subinit 50 mg kapsułki twarde
mt pharma-healthcare sp. z o.o. - sunitinibum - kapsułki twarde - 50 mg
rivaroxaban accord
accord healthcare s.l.u. - rywaroksaban - acute coronary syndrome; coronary artery disease; peripheral arterial disease; venous thromboembolism; stroke; atrial fibrillation; pulmonary embolism - Środki przeciwzakrzepowe - profilaktyka żylnej choroby zakrzepowo-zatorowej (Żchzz) u dorosłych pacjentów poddawanych planowej operacji wymiany stawu biodrowego lub kolanowego. leczenie zakrzepicy żył głębokich (dvt) i zatorowości płucnej (ТЭЛА) i zapobiegania nawrotom zakrzepicy żył głębokich i ТЭЛА u dorosłych. (see section 4. 4 for haemodynamically unstable pe patients. leczenie zakrzepicy żył głębokich (dvt) i zatorowości płucnej (ТЭЛА) i zapobiegania nawrotom zakrzepicy żył głębokich i ТЭЛА u dorosłych. (see section 4. 4 hemodynamicznie niestabilna ТЭЛА pacjentów). adultsprevention of stroke and systemic embolism in adult patients with non valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. leczenie zakrzepicy żył głębokich (dvt) i zatorowości płucnej (ТЭЛА) i zapobiegania nawrotom zakrzepicy żył głębokich i ТЭЛА u dorosłych. (see section 4. 4 for haemodynamically unstable pe patients. )paediatric populationtreatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. rivaroxaban accord, co administered with acetylsalicylic acid (asa) alone or with asa plus ticlopidine, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers (see sections 4. 3, 4. 4 i 5. rivaroxaban accord, co administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events. adultsprevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. leczenie zakrzepicy żył głębokich (dvt) i zatorowości płucnej (ТЭЛА) i zapobiegania nawrotom zakrzepicy żył głębokich i ТЭЛА u dorosłych. (see section 4. 4 for haemodynamically unstable pe patients. )paediatric populationtreatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.
amiodaron accord 30 mg/ml koncentrat do sporządzania roztworu do wstrzykiwań / do infuzji
accord healthcare polska sp. z o.o. - amiodaroni hydrochloridum - koncentrat do sporządzania roztworu do wstrzykiwań / do infuzji - 30 mg/ml